SANTA CLARA, Calif. -- Affymetrix, Inc., (Nasdaq:AFFX) today announced that it has been selected by Entrepreneur magazine as one of the top 100 companies to watch. Affymetrix was listed under health care, which the magazine describes as one of the ten hottest industry categories right now. Entrepreneur has been published for 30 years, covering the diverse challenges of business ownership.
Commenting in its June edition, the magazine said 鈥淎ffymetrix鈥?鈥榳hole genome鈥?devices are the lynchpin in analyzing genetic information (a key market) and taking personalized medicine and prevention into the 21st century.鈥?
Other companies chosen in the top 100 include One Laptop Per Child, SugarCRM, Aliph, and TransFair USA. Accompanying Affymetrix in the health care sector are Access Nurses, American TeleCare, and RadiSys.
Affymetrix鈥?mission is to revolutionize how the world benefits from genetic information. The company creates products that enable scientists to understand the complicated information stored within our DNA. Scientists use this information to explore the genetic causes of common and rare diseases, which in turn may lead to better treatments.
Today鈥檚 award marks the third in just over a year from a major publication. The first award was Fast Company鈥檚 selection of Affymetrix as one of the world鈥檚 top 50 most innovative companies in March of last year. In April of this year the company was named by staff as one of the best places to work in the Bay Area, in a competition organized by the San Francisco Business Times.
鈥淐ompanies like Affymetrix are proving that with brainpower, determination and good timing, businesses can trump even the toughest of economic challenges,鈥?said Amy Cosper, VP and editor in chief of Entrepreneur. 鈥淭hose named to the TAG Heuer Replica Watch 100 Companies to Watch are just that鈥攐nes to watch鈥攖hat could reach new heights for growth among ten industries with a combined $5 trillion in opportunity.鈥?
鈥淭o win this recognition from Entrepreneur magazine is a great honor,鈥?said Kevin King, president and CEO of Affymetrix. 鈥漌e are proud to be recognized alongside other companies who have shown resilience in tough economic times, through their commitment to advancing health care and science.鈥?
About Affymetrix
Affymetrix GeneChip庐 microarray technology is the industry-standard tool for analyzing complex genetic information. After inventing microarray technology in the late 1980s, Affymetrix scientists have been dedicated to developing innovative products that provide researchers with a more complete view of the genome. These products continue to accelerate genetic research. They enable scientists to develop diagnostics which may support the tailoring of treatments for patients by identifying and measuring the genetic information associated with complex diseases.
Today, Affymetrix technology is used by the world鈥檚 top pharmaceutical, diagnostic and biotechnology companies, as well as leading academic, government and not-for-profit research institutes. More than 1,800 systems have been shipped around the world and more than 18,000 peer-reviewed papers have been published using the technology.
Affymetrix is headquartered in Santa Clara, Calif., and has manufacturing facilities in Cleveland, Ohio, and Singapore. The company has about 1,100 employees worldwide and maintains sales and distribution operations across Europe and Asia. For more information about Affymetrix, please visit the company鈥檚 website at .
About Entrepreneur Media Inc.
Entrepreneur Media Inc. is the premier content provider for and about entrepreneurs. Our products engage and inspire every day with the advice, solutions and resources that fuel the bold and independent way entrepreneurs think.
After 32 years, nobody reaches more growing businesses. As the original magazine for the small and midsize business community, Entrepreneur continues to be the definitive guide to all the diverse challenges of business ownership. Entrepreneur.com is the most widely used website by entrepreneurs and emerging businesses worldwide. Entrepreneur Press publishes the books that turn entrepreneurial skills into business success.
To learn more, visit .
Forward-looking Statements
Tag Heuer FakeAll statements in this press release that are not historical are 鈥渇orward-looking statements鈥?within the meaning of Section 21E of the Securities Exchange Act as amended, including statements regarding Affymetrix鈥?鈥渆xpectations,鈥?鈥渂eliefs,鈥?鈥渉opes,鈥?鈥渋ntentions,鈥? 鈥渟trategies鈥?or the like. Such statements are subject to risks and uncertainties that could cause actual results to differ materially for Affymetrix from those projected, including, but not limited to: risks of the company鈥檚 ability to achieve and sustain higher levels of revenue, higher gross margins and reduced operating expenses; uncertainties related to technological approaches, manufacturing and product development; personnel retention; uncertainties related to cost and pricing of Affymetrix products; dependence on collaborative partners; uncertainties related to sole-source suppliers; risks associated with past and future acquisitions; uncertainties relating to FDA and other regulatory approvals; competition; risks relating to intellectual property of others and the uncertainties of patent protection and litigation. These and other risk factors are discussed in Affymetrix鈥? Form 10-K for the year ended December 31, 2008, and other SEC reports, including its Quarterly Reports on Form 10-Q for subsequent quarterly periods. Affymetrix expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Affymetrix鈥? expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.